Last reviewed · How we verify
NCT02064634
A Multicenter, Comparative, Open Label, Prospective Observational Study on Discontinuation of Medication Due to Gastrointestinal Adverse Effects for the Patients Being Treated for Osteoarthritis With Anti-inflammatory Analgesic Drug
trial in Osteoarthritis in 6,700 participants. Status unknown.
1 June 2016
Quick facts
| Lead sponsor | Green Cross Corporation |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 6,700 |
| Start date | 1 May 2014 |
| Primary completion | 1 June 2016 |
| Estimated completion | 1 December 2016 |
| Sites | 1 location across South Korea |
Conditions studied
- Osteoarthritis — all drugs for Osteoarthritis →
Sponsor
Green Cross Corporation — full company profile →
Who can join
20 and older, any sex, with Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Discontinuation rate due to gastrointestinal adverse effects
Time frame: up to 12 weeks
Sponsor's own description
This study investigates how gastrointestinal toxicity affects discontinuation of medication given to patients with osteoarthritis in routine clinical practice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02064634
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoarthritis
Currently open trials in the same condition.
- NCT07404891 — Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis · NA · recruiting
- NCT07118501 — A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System · recruiting
- NCT06631638 — EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)) · NA · recruiting
- NCT07198750 — "Bimodal vs Unimodal High-Intensity Pulsed Electromagnetic Field Therapy in Older Adults With Knee Osteoarthritis" · NA · recruiting
- NCT07006714 — Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA) · Phase 4 · active not recruiting
Other Green Cross Corporation trials
Trials by the same sponsor.
- NCT01624532 — A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 · Phase 2 · completed
- NCT04555148 — COVIDIG (COVID-19 Hyper-ImmunoGlobulin) · Phase 2 · completed
- NCT04175522 — Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis: · Phase 2 · completed
- NCT03947138 — A Study of GC3107(BCG Vaccine) in Healthy Infants · Phase 3 · completed
- NCT03492710 — Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency · Phase 3 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02064634 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Green Cross Corporation
- Last refreshed: 15 March 2016
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02064634.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing